Emmessar Biotech Sees Profit Jump Amid Sales Dip

Emmessar Biotech & Nutrition has reported a net profit of Rs 0.03 crore for the quarter ending March 2026. This marks a significant improvement from the net loss of Rs 0.07 crore recorded in the same quarter of the previous year. However, the company's sales for this period saw a 10% decrease, falling to Rs 0.09 crore from Rs 0.10 crore in the prior year.

Looking at the full fiscal year ending March 2026, Emmessar Biotech & Nutrition's net profit saw a substantial increase of 37.50%, reaching Rs 0.44 crore. This contrasts with Rs 0.32 crore reported for the previous fiscal year. Despite the improved profitability, the company's sales for the full year declined by 39.34%, amounting to Rs 0.37 crore compared to Rs 0.61 crore in the prior year.